| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 102.149 | 76 |
| GSM780708 | Untreated after 4 days (C2_1) | 93.5535 | 74 |
| GSM780709 | Untreated after 4 days (C3_1) | 106.692 | 76 |
| GSM780719 | Untreated after 4 days (C1_2) | 123.85 | 78 |
| GSM780720 | Untreated after 4 days (C2_2) | 81.1186 | 72 |
| GSM780721 | Untreated after 4 days (C3_2) | 76.6711 | 71 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 92.6729 | 74 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 112.345 | 77 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 122.793 | 78 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 114.542 | 77 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 90.7167 | 74 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 104.443 | 76 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 136.644 | 79 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 108.658 | 76 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 84.3217 | 73 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 129.822 | 79 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 148.605 | 80 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 121.478 | 78 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 85.0263 | 73 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 129.859 | 79 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 96.1293 | 75 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 117.569 | 77 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 98.7143 | 75 |